GA: 4P Therapeutics Celebrates Headquarters Opening in Gwinnett County | Trade and Industry Development

GA: 4P Therapeutics Celebrates Headquarters Opening in Gwinnett County

Jul 08, 2013

Transdermal research and development company, 4P Therapeutics, will join Gwinnett Chamber Economic Development to celebrate the opening of its headquarters facility in the City of Peachtree Corners, Gwinnett County. Bringing an initial 12 new jobs to the County, the announcement represents $250,000 in capital investment for the community.

"Our new facility in Gwinnett will allow us to continue to enhance our research efforts, expand the company, and take advantage of the resources available to growing life sciences companies in Georgia," stated Steven Damon, President & CEO of 4P Therapeutics. "With access to the region's research support, top-rated universities, and biotechnology infrastructure, we are well positioned to expand our capabilities and products."

Located at 680 Engineering Dr., Suite 150, the facility is 8,000 square feet, with the addition of another 5,000 square feet anticipated by the end of 2013. A transdermal product research and development company, 4P Therapeutics focuses on developing drugs currently marketed as an infusion or injection into a patch version.

"4P Therapeutics is a fantastic addition to Gwinnett's strong and growing bioscience industry," commented Gwinnett County Commission Chairman Charlotte Nash. "With direct access to the resources, opportunities, and support that help companies like 4P Therapeutics thrive, Gwinnett County is poised to remain a leader in life sciences."

"On behalf of Peachtree Corners, I want to welcome 4P Therapeutics to our city. 4P Therapeutics joins a host of life science companies and further positions the community for sustained economic growth driven by research, development, and the commercialization of new products and technologies," stated City of Peachtree Corners Mayor Mike Mason.

4P Therapeutics' location positions the company within the region's Innovation Crescent, both a geographic area and coalition of more than a dozen counties and economic development entities, all dedicated to supporting Georgia's life science growth. A corridor spanning from Atlanta to Athens-Clarke County, the Innovation Crescent encompasses the resources of top research organizations in the Southeast contributing to life science exploration. A member of the Innovation Crescent, Gwinnett Chamber Economic Development strives to support and promote the growth of Life Science companies, such as 4P Therapeutics, within the Gwinnett and metro Atlanta community.

"4P Therapeutics is the type of thriving company we aim to attract, nurture, and retain in Georgia's vibrant Innovation Crescent and I am excited to welcome them to the region," said Nick Masino, Chair of Georgia's Innovation Crescent and Senior Vice President of Gwinnett Chamber Economic Development and Partnership Gwinnett. "We look forward to supporting 4P Therapeutics in Gwinnett, where we have proven that we have the talent and resources to help life science companies prosper."

To learn more about 4P Therapeutics, please visit www.4ptherapeutics.com.

For more information, or to learn how to get involved in local economic development efforts, please visit
www.gwinnetteconomicdevelopment.com.

About Gwinnett Chamber Economic Development

Gwinnett Chamber Economic Development globally markets Gwinnett as the premier location in metro Atlanta and the State of Georgia for growing and conducting business. By encouraging investment and trade into the county through relocation and expansion assistance, the organization works with local and regional partners to bring technology, health sciences and services, advanced manufacturing, supply chain management, and corporate headquarters to the community. Home to FORTUNE 500 and 1000 companies, Gwinnett County hosts a wide range of businesses from industry giants, to international companies and homegrown start-ups.
Success lives here - www.gwinnetteconomicdevelopment.com.

(Click to Expand)